Surfing NASH reports on-site coverage from EASL Congress 2023 in Vienna. Ian Rowe, Michael Betel, Jörn Schattenberg and Roger Green get together early in the morning to compare notes and takeaways from an energizing meeting.
In an extra-sode with Arun Sanyal, David Kleiner and Roger Green, the podcast investigates challenges in using ordinal manual histopathology in NASH clinical trials and how AI systems might ameliorate or minimize these challenges.
This final preview featuring the thoughts and anticipations of Louise Campbell and Roger Green explores the idea of harnessing technology to maximize the utility of databases in the effort of identifying patients.
This conversation covers final thoughts on the anticipations of Ian Rowe, Jörn Schattenberg and Roger Green heading into EASL Congress 2023. The group primarily explores a session on NAFLD clinical aspects which provides practical presentations around tools available now for treating and managing patients with NASH.
This conversation with Ian Rowe, Jörn Schattenberg and Roger Green continues to unpack the rich EASL Congress 2023 program by discussing abstracts and presentations of interest. The group dives deep into liver science with commentary around emerging developments in NAFLD/NASH therapeutics.
This conversation with Ian Rowe, Jörn Schattenberg and Roger Green begins to unpack the rich EASL Congress 2023 program and explore in detail presentations of interest. Specifically, the group dives into anticipations around an abstract session around diagnostics and non-invasive assessment.
This episode comprises three separate sessions as part of the Surfing NASH ongoing coverage of a highly anticipated EASL Congress 2023. The first two discussions feature Ian Rowe, Jörn Schattenberg, Louise Campbell and Roger Green as the group reviews their lists of abstracts to look forward to. Following is an extra-sode on the subject of AI and pathology with guests Arun Sanyal and David Kleiner.
The podcast celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. This conversation offers observations around the new NICE guidance that supports FibroScan use in primary care settings. The group ventures on to discuss the effects of socioeconomic status on access to improved liver health.
The podcast celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. This conversation reviews the unique ways different organizations from across the world have interacted with and shown support for #NASHDay 2023.
William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This final conversation addresses a closing question around the future of FibroScan and how NICE will have progressed on the issue over the next 18 months.
